Skip to Main Content

Kevan Herold, MD

Endocrinology, Pediatric Endocrinology & Diabetes, Diabetes Medicine & Management
Telehealth is available
Learn more about telehealth
Patient type treated
Child, Adult
Accepting new patients
Referral required
From patients or physicians
Board Certified in
Endocrinology & Metabolism and Internal Medicine


My background and research are in translational immunology. I am interested in understanding the basis for autoimmune diseases and developing new therapies based on our understanding of disease mechanisms. My focus has largely been in the field of autoimmune Type 1 diabetes. The work encompasses basic laboratory work as well as clinical studies to understanding the regulation of autoreactive T cells to clinical trials that involve novel therapeutics. As part of these studies I have also been very interested in analysis of beta cell function in Type 1 diabetes. As part of this interest, we have been studying the development of autoimmune diabetes in patients with cancers who are treated with checkpoint inhibitors. Our clinical and basic studies are focused on understanding how beta cells are destroyed and react to inflammation. Finally, with the COVID-19 pandemic, we have been studying the immunologic basis for responses in children and adults who are hospitalized with COVID-19 to understand the mechanisms that can lead to disease protection. 


  • C.N.H. Long Professor of Immunobiology and of Medicine (Endocrinology)

Education & Training

  • Fellow
    University of Chicago (1984)
  • Residency
    Temple University Hospital (1982)
  • MD
    Jefferson Medical College (1979)
  • BS
    Pennsylvania State University (1977)

Additional Information

  • Yale Endocrinology
    Dana Clinic Building
    789 Howard Avenue, Fl 2nd
    New Haven, CT, 06519
  • Yale Endocrinology & Metabolism
    Yale New Haven Hospital
    20 York Street
    New Haven, CT, 06510